/Companies

Edgc

Incheon, KR · 1 known investors

Find your way into Edgc

Sign up to see every warm intro you have to Edgc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Edgc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

EDGC (Eone-Diagnomics Genome Center) is a Korean genomics healthcare company that provides genetic analysis services across life stages, including non-invasive prenatal testing (NIPT) branded "The Mom's Scanning" and liquid biopsy-based cancer diagnostics using cell-free DNA and next-generation sequencing. Listed on KOSDAQ, it offers its prenatal testing in around 40 countries and positions itself as an AI genomics company.

Founders & leadership

MLMin-Seob Lee
Min-Seob LeeCEOMin-Seob Lee is CEO of EDGC, a Korean genomics healthcare company offering genetic analysis services including non-invasive prenatal testing and liquid biopsy-based cancer diagnostics. He holds technical expertise in molecular biology, sequencing, and bioinformatics, with experience developing and managing diagnostic products in regulated laboratory settings.

Investors · 1

Frequently asked questions

What does Edgc do?
EDGC (Eone-Diagnomics Genome Center) is a Korean genomics healthcare company that provides genetic analysis services across life stages, including non-invasive prenatal testing (NIPT) branded "The Mom's Scanning" and liquid biopsy-based cancer diagnostics using cell-free DNA and next-generation sequencing. Listed on KOSDAQ, it offers its prenatal testing in around 40 countries and positions itself as an AI genomics company.
Who are Edgc's investors?
Edgc's investors include Aju IB Investment.
Where is Edgc headquartered?
Edgc is headquartered in Incheon, KR.